Dr. Loeb on Active Surveillance for Prostate Cancer

Stacy Loeb, MD
Published: Friday, May 12, 2017



Stacy Loeb, MD, assistant professor of Urology and Population Health at New York University, discusses active surveillance for patients with low-risk prostate cancer.

Active surveillance is a growing management option for patients with low-risk prostate cancer, states Loeb.

One of the concerns is that the risk classification for patients with prostate cancer is not completely accurate, explains Loeb. Genomic tests are being studied to confirm that patients are categorized appropriately.
 


Stacy Loeb, MD, assistant professor of Urology and Population Health at New York University, discusses active surveillance for patients with low-risk prostate cancer.

Active surveillance is a growing management option for patients with low-risk prostate cancer, states Loeb.

One of the concerns is that the risk classification for patients with prostate cancer is not completely accurate, explains Loeb. Genomic tests are being studied to confirm that patients are categorized appropriately.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Publication Bottom Border
Border Publication
x